Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice

Bogdan Wlodarczyk, Ofer Spiegelstein, Janee Gelineau-van Waes, Roseann L. Vorce, Xiufen Lu, Chris X. Le, Richard H. Finnell

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Arsenic is a well-known carcinogen, which has been suspected of being a human teratogen, although there is currently insufficient and inadequate supportive data to make any definitive judgments. In addition, the significance of individual genetic differences on pregnancy outcomes following in utero exposure to arsenic is currently unknown. In order to better understand the role of folate transport mechanisms in arsenic-induced neural tube defects, we examined the effect of in utero exposure to sodium arsenate in a genetically altered murine model in which the folate binding protein 2 (Folbp2) gene has been inactivated by homologous recombination. In utero sodium arsenate exposure induced exencephaly in 40.6% of Folbp2-/- embryos compared with 24.0% in control Folbp2+/+ embryos. The differences in response frequencies were further exacerbated when the dams were fed a folate-deficient diet. Under these conditions, exencephaly was observed in 64.0% of Folbp2-/- embryos compared with 25.7% in control Folbp2+/+ embryos. Analysis of arsenic metabolites excreted in the urine following sodium arsenate injection to Folbp2-/- and Folbp2+/+ mice indicated that there were no significant differences in arsenic metabolism between the two groups. Thus, the increased susceptibility of Folbp2-/- mice to arsenate-induced teratogenicity may not be due to differences in biomethylation and exposure. In conclusion, the data suggest that impaired folate transport in the developing mouse embryo increases the risk for developmental defects following in utero exposure to sodium arsenate and that these differences are not due to differences in metabolism of arsenic.

Original languageEnglish
Pages (from-to)238-246
Number of pages9
JournalToxicology and Applied Pharmacology
Volume177
Issue number3
DOIs
StatePublished - Dec 15 2001
Externally publishedYes

Fingerprint

Arsenic
Folic Acid
Knockout Mice
Carrier Proteins
Embryonic Structures
Neural Tube Defects
Metabolism
Teratogens
Defects
Homologous Recombination
Pregnancy Outcome
Nutrition
Metabolites
Individuality
Carcinogens
Dams
Frequency response
Genes
Urine
Diet

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Toxicology

Cite this

Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. / Wlodarczyk, Bogdan; Spiegelstein, Ofer; Gelineau-van Waes, Janee; Vorce, Roseann L.; Lu, Xiufen; Le, Chris X.; Finnell, Richard H.

In: Toxicology and Applied Pharmacology, Vol. 177, No. 3, 15.12.2001, p. 238-246.

Research output: Contribution to journalArticle

Wlodarczyk, Bogdan ; Spiegelstein, Ofer ; Gelineau-van Waes, Janee ; Vorce, Roseann L. ; Lu, Xiufen ; Le, Chris X. ; Finnell, Richard H. / Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. In: Toxicology and Applied Pharmacology. 2001 ; Vol. 177, No. 3. pp. 238-246.
@article{3b98b0922439467d89dd0c35b8824a23,
title = "Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice",
abstract = "Arsenic is a well-known carcinogen, which has been suspected of being a human teratogen, although there is currently insufficient and inadequate supportive data to make any definitive judgments. In addition, the significance of individual genetic differences on pregnancy outcomes following in utero exposure to arsenic is currently unknown. In order to better understand the role of folate transport mechanisms in arsenic-induced neural tube defects, we examined the effect of in utero exposure to sodium arsenate in a genetically altered murine model in which the folate binding protein 2 (Folbp2) gene has been inactivated by homologous recombination. In utero sodium arsenate exposure induced exencephaly in 40.6{\%} of Folbp2-/- embryos compared with 24.0{\%} in control Folbp2+/+ embryos. The differences in response frequencies were further exacerbated when the dams were fed a folate-deficient diet. Under these conditions, exencephaly was observed in 64.0{\%} of Folbp2-/- embryos compared with 25.7{\%} in control Folbp2+/+ embryos. Analysis of arsenic metabolites excreted in the urine following sodium arsenate injection to Folbp2-/- and Folbp2+/+ mice indicated that there were no significant differences in arsenic metabolism between the two groups. Thus, the increased susceptibility of Folbp2-/- mice to arsenate-induced teratogenicity may not be due to differences in biomethylation and exposure. In conclusion, the data suggest that impaired folate transport in the developing mouse embryo increases the risk for developmental defects following in utero exposure to sodium arsenate and that these differences are not due to differences in metabolism of arsenic.",
author = "Bogdan Wlodarczyk and Ofer Spiegelstein and {Gelineau-van Waes}, Janee and Vorce, {Roseann L.} and Xiufen Lu and Le, {Chris X.} and Finnell, {Richard H.}",
year = "2001",
month = "12",
day = "15",
doi = "10.1006/taap.2001.9303",
language = "English",
volume = "177",
pages = "238--246",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice

AU - Wlodarczyk, Bogdan

AU - Spiegelstein, Ofer

AU - Gelineau-van Waes, Janee

AU - Vorce, Roseann L.

AU - Lu, Xiufen

AU - Le, Chris X.

AU - Finnell, Richard H.

PY - 2001/12/15

Y1 - 2001/12/15

N2 - Arsenic is a well-known carcinogen, which has been suspected of being a human teratogen, although there is currently insufficient and inadequate supportive data to make any definitive judgments. In addition, the significance of individual genetic differences on pregnancy outcomes following in utero exposure to arsenic is currently unknown. In order to better understand the role of folate transport mechanisms in arsenic-induced neural tube defects, we examined the effect of in utero exposure to sodium arsenate in a genetically altered murine model in which the folate binding protein 2 (Folbp2) gene has been inactivated by homologous recombination. In utero sodium arsenate exposure induced exencephaly in 40.6% of Folbp2-/- embryos compared with 24.0% in control Folbp2+/+ embryos. The differences in response frequencies were further exacerbated when the dams were fed a folate-deficient diet. Under these conditions, exencephaly was observed in 64.0% of Folbp2-/- embryos compared with 25.7% in control Folbp2+/+ embryos. Analysis of arsenic metabolites excreted in the urine following sodium arsenate injection to Folbp2-/- and Folbp2+/+ mice indicated that there were no significant differences in arsenic metabolism between the two groups. Thus, the increased susceptibility of Folbp2-/- mice to arsenate-induced teratogenicity may not be due to differences in biomethylation and exposure. In conclusion, the data suggest that impaired folate transport in the developing mouse embryo increases the risk for developmental defects following in utero exposure to sodium arsenate and that these differences are not due to differences in metabolism of arsenic.

AB - Arsenic is a well-known carcinogen, which has been suspected of being a human teratogen, although there is currently insufficient and inadequate supportive data to make any definitive judgments. In addition, the significance of individual genetic differences on pregnancy outcomes following in utero exposure to arsenic is currently unknown. In order to better understand the role of folate transport mechanisms in arsenic-induced neural tube defects, we examined the effect of in utero exposure to sodium arsenate in a genetically altered murine model in which the folate binding protein 2 (Folbp2) gene has been inactivated by homologous recombination. In utero sodium arsenate exposure induced exencephaly in 40.6% of Folbp2-/- embryos compared with 24.0% in control Folbp2+/+ embryos. The differences in response frequencies were further exacerbated when the dams were fed a folate-deficient diet. Under these conditions, exencephaly was observed in 64.0% of Folbp2-/- embryos compared with 25.7% in control Folbp2+/+ embryos. Analysis of arsenic metabolites excreted in the urine following sodium arsenate injection to Folbp2-/- and Folbp2+/+ mice indicated that there were no significant differences in arsenic metabolism between the two groups. Thus, the increased susceptibility of Folbp2-/- mice to arsenate-induced teratogenicity may not be due to differences in biomethylation and exposure. In conclusion, the data suggest that impaired folate transport in the developing mouse embryo increases the risk for developmental defects following in utero exposure to sodium arsenate and that these differences are not due to differences in metabolism of arsenic.

UR - http://www.scopus.com/inward/record.url?scp=0035894337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035894337&partnerID=8YFLogxK

U2 - 10.1006/taap.2001.9303

DO - 10.1006/taap.2001.9303

M3 - Article

C2 - 11749123

AN - SCOPUS:0035894337

VL - 177

SP - 238

EP - 246

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -